Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYMEWORKS INC (US)

16.30
-0.0600-0.37%
Post-market: 16.01-0.2900-1.78%17:33 EDT
Volume:521.16K
Turnover:8.49M
Market Cap:1.23B
PE:-16.66
High:16.61
Open:16.44
Low:16.06
Close:16.36
52wk High:17.70
52wk Low:9.03
Shares:75.58M
Float Shares:38.30M
Volume Ratio:0.67
T/O Rate:1.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9781
EPS(LYR):-1.6177
ROE:-19.89%
ROA:-11.19%
PB:3.68
PE(LYR):-10.08

Loading ...

Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Zymeworks (ZYME)

TIPRANKS
·
Sep 19

BUZZ-U.S. STOCKS ON THE MOVE-PepsiCo, Ionis Pharma, United Therapeutics

Reuters
·
Sep 02

Zymeworks Shares Dip 2.8% Premarket After Co Halts Development of Its Cancer Drug

THOMSON REUTERS
·
Sep 02

Zymeworks halts development of cancer drug after trial setback

Reuters
·
Sep 02

Zymeworks Inc. Announces Initiation of Phase 1 Study for ZW251 and Plans IND Filing for ZW209 in 2026

Reuters
·
Sep 02

Zymeworks Announces Decision to Discontinue Clinical Development of ZW171, a Mesothelin-Directed T Cell Engager

THOMSON REUTERS
·
Sep 02

Zymeworks Inc - Further Dose Evaluation Unlikely to Support Profile

THOMSON REUTERS
·
Sep 02

Zymeworks Inc - Preparing an Ind Filing for ZW209, Our Dll3-Directed Trispecific T Cell Engager, Planned in First Half of 2026

THOMSON REUTERS
·
Sep 02

Zymeworks Inc. Set to Participate in Citi's Biopharma Back to School Conference

Reuters
·
Aug 19

Zymeworks Inc. Files Initial Statement of Beneficial Ownership for Director Gregory Austin Ciongoli

Reuters
·
Aug 13

Stock Track | Zymeworks (ZYME) Soars 5.06% as Leerink Partners Reiterates Buy Rating with $30 Price Target

Stock Track
·
Aug 13

Stock Track | Zymeworks Soars 5.06% After Leerink Partners Reiterates Buy Rating with $30 Price Target

Stock Track
·
Aug 13

Zymeworks Inc. Strengthens Board with Appointments of Greg Ciongoli and Robert E. Landry

Reuters
·
Aug 11

Zymeworks Inc : Citigroup Raises Target Price to $22 From $19

THOMSON REUTERS
·
Aug 11

Zymeworks Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08

Biotech firm Zymeworks' Q2 revenue jumps to $48.7 mln

Reuters
·
Aug 08

Zymeworks Q2 EPS $0.03 Beats $(0.49) Estimate, Sales $48.73M Beat $19.38M Estimate

Benzinga
·
Aug 08

Zymeworks Q2 EPS USD 0.03

THOMSON REUTERS
·
Aug 08

Zymeworks Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
Aug 06

Zymeworks Inc - Phase 1 Trial for ZW251 in Hcc Expected in 2025

THOMSON REUTERS
·
Jul 28